India, Feb. 7 -- Sigachi Industries Limited, a leading player in the pharmaceutical industry, is strengthening its research and development (R&D) capabilities with a $1 million investment in a state-of-the-art R&D centre in Hyderabad. This initiative aims to bring API development and analytical efforts under one roof, optimising production processes and driving innovation.

The new facility will play a crucial role in enhancing API synthesis, streamlining the pharma product portfolio, and ensuring adherence to stringent global regulatory standards.

Sigachi is intensifying its R&D investments to drive high-value innovation, with plans to fuel additional 6 CEP's over the next six months. The centre will also house a team of 15-20 experienc...